Navigation Links
MDS Pharma Services Names Rudy Howard Chief Financial Officer

KING OF PRUSSIA, PA, Jan. 7 /PRNewswire-FirstCall/ - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, today announced the appointment of Rudy Howard as Senior Vice-President and Chief Financial Officer.

Mr. Howard has extensive experience as a senior financial executive in the pharmaceutical and contract research organization (CRO) industry sectors, including six years as CFO at Pharmaceutical Product Development, Inc. He joins MDS Pharma Services from his private consulting practice where he offered business and financial consulting services, including merger and acquisition services, for clients across a variety of industries, including pharmaceutical and biotechnology.

"We are delighted to add someone with Rudy's breadth and depth of skills and expertise to our leadership team at MDS Pharma Services," said MDS Pharma Services President David Spaight. "His impressive portfolio of financial, business development and change management capabilities in the pharmaceutical and contract research industries makes him an excellent choice to lead the MDS Pharma Services finance organization at this time."

Before founding his consulting practice, Mr. Howard was CFO at Peopleclick Inc., a human resources software-development company. Previously, he was a Partner at PricewaterhouseCoopers, where his specialization included financial services, high technology, pharmaceuticals and manufacturing. He began his career in public accounting with Deloitte and Touche LLP.

About MDS Pharma Services

MDS Pharma Services is committed to delivering quality service on-time. We offer a full spectrum of resources to meet the drug-discovery and development needs of the pharmaceutical and biotechnology industries. With numerous facilities strategically located around the world, we apply advanced scientific and technological expertise throughout the drug discovery and development process - from lead optimization, pre-IND research, early clinical research (bioequivalence, phases I-IIa) and bioanalysis through to global clinical development (phases IIb-IV), central lab and centralized cardiac services. For more information, visit our website at

MDS Pharma Services is a business unit of MDS Inc. (TSX: MDS; NYSE: MDZ), a global life-sciences company that provides market-leading products and services that our customers need for the development of drugs and diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS has more than 5,000 highly skilled people in 29 countries. Find out more at or by calling 1-888-MDS-7222, 24 hours a day.

SOURCE MDS Pharma Services
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NABP Expanding Computer-Based Test Delivery to Include Foreign Pharmacy Graduate Equivalency Examination(R)
2. MiddleBrook Pharmaceuticals to Launch Moxatag(TM) March 2009
3. M Resort, Spa and Casino to Include On-Property Pharmacy
4. Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company License to Certain Alzheimers Patents and Patent Applications
5. Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference
6. Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO
7. BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent
8. Halo Pharmaceutical, Inc. Acquires Whippany Manufacturing Facility from Abbott
9. Kyp Systems Takes on the Challenge of New Pharmaceutical Marketing Guidelines
10. Akrimax Pharmaceuticals Announces Manufacturing Partnership
11. Prism Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
(Date:6/26/2016)... ... 27, 2016 , ... Quality metrics are proliferating in cancer care, and are ... the eye of the beholder, according to experts who offered insights and commentary in ... Managed Care. For the full issue, click here . , For the American ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas ... Brasil as the company,s second affiliate in Latin America . ... ... of Astellas Farma Colombia ... ...
(Date:6/23/2016)... The vast majority of dialysis patients currently ... are usually 3 times a week, with treatment times ... time, equipment preparation and wait time.  This regimen can ... patients who are elderly and frail.  Many elderly dialysis ... centers for some duration of time. Residents ...
(Date:6/23/2016)... YORK , June 23, 2016 ... waters, but it continues to present great opportunities to ... companies for today: Intrexon Corp. (NYSE: XON ... Arena Pharmaceuticals Inc. (NASDAQ: ARNA ), and ... more about these stocks and receive your complimentary trade ...
Breaking Medicine Technology: